AssayIndex

AX-2026-042064

Triptorelin · 5 mg declared · Shenzhen Hybio Pharmaceutical Co., Ltd. · lot HYB-2512-B7307

FAILIDENTITY CONSISTENT
Report ID
AX-2026-042064
Compound
Triptorelin
Compound class
Hypothalamic and posterior-pituitary hormones
Supplier
HYB — Shenzhen Hybio Pharmaceutical Co., Ltd.
Batch / lot
HYB-2512-B7307
Declared label claim
5mg
Laboratory
Medutest
Assay date
28 Feb 2026
Submitted
09 Mar 2026
Quarter
2026-Q1
Submitter
b.abubakar
Sample provenance
Buyer-sourced
Section 1

Results

Measured against the index acceptance specification for the hypothalamic and posterior-pituitary hormones class. A specification is a decision the index made; a result is a measurement. See where each threshold came from.

ParameterMethodResultUnitIndex spec
PurityRP-HPLC, 25 min gradient, 214 nm99.46% area≥ 98.5PASS
Total impuritiesRP-HPLC, sum of reported peaks0.54% area≤ 1.5PASS
Largest single impurityRP-HPLC — ring-opened pGlu (+18 Da)0.24% area≤ 1.00PASS
Identity — theoretical monoisotopic masscalculated from molecular formula1310.6248DaNOT TESTED
Identity — observed monoisotopic massLC-MS, unit resolution (single quadrupole)1310.6485DaNOT TESTED
Mass accuracyobserved vs theoretical+18.1ppm± 15FAIL
Total peptide contentby difference from the gravimetric mass balance91.26%w/wNOT TESTED
Target-compound contenttotal peptide content × purity90.77%w/wNOT TESTED
Gross fill (as weighed)five-place balance, under nitrogen4.96mg5 mg declaredNOT TESTED
Recovered target peptidegross fill × target content4.502mg5 mg claimNOT TESTED
Recovery against label claimrecovered ÷ claim90.0%90.0 – 110.0PASS
Water contentKarl Fischer, coulometric, duplicate4.18%≤ 8.0PASS
Counter-ion (acetate)anion-exchange ion chromatography4.09%≤ 10.0PASS
Residual solvent + inorganic residueestimated — see /methods/residual-solvents-q3c/0.47%NOT TESTED
Endotoxinnot ordered on this submissionnot determined≤ 5.0NOT TESTED
Sterilitynot ordered on this submissionnot determinedno growthNOT TESTED
Appearancevisual, diffuse light, black and white backgroundWhite lyophilised cake, intactwhite to off-white intact cakePASS
Reconstitution clarityreconstituted per submitter procedureClear, colourless, no visible particulatesclear, no visible particulatesPASS
pH (reconstituted, 1 mg/mL)potentiometric, two-point calibration5.452.5 – 8.0PASS
Retention time (observed)RP-HPLC, 25 min gradient8.29min8.23 ± 0.25 (normalised)PASS
Peak asymmetry (10 % height)Ph. Eur. 2.2.461.090.80 – 1.50PASS
Plate count, main peakN = 5.54 (t/w½)²67,338≥ 20,000PASS
Resolution to nearest impurityvs [L-Trp6]-diastereomer (gonadorelin analogue)1.27no index criterionREPORTED
Section 2

Chromatogram and peak integration

The figure is drawn from the table. It is not an independent illustration — if a number in the table changed, the trace would change with it.

0344968971034613795 Triptorelin8.29 min · 99.46 % 7.89 same trace · ×200 vertical expansion, baseline-corrected · main peak off-scale reporting threshold 0.05 % area 0481216202428 Retention time (min) Response (mAU)
Figure 1. RP-HPLC trace, 25 min gradient, 214 nm. Drawn from the peak-integration table below: peak positions are the reported retention times, peak areas are the reported area percentages, peak widths follow the reported plate count of 67,338, and skew follows the reported asymmetry factor of 1.09. Baseline noise is seeded from the report ID and is illustrative. The lower panel is the same trace at a stated vertical expansion with the slow gradient drift subtracted, because at full scale a 0.24 % impurity against a 99.46 % main peak is a line two pixels tall; the main peak runs off-scale there by design.
#PeakRTArea (µV·s)% areaΔ mass (Da)
1Triptorelin — main peak8.294,834,06499.46
2ring-opened pGlu (+18 Da)7.8911,6650.24+18.011
3[L-Trp6]-diastereomer (gonadorelin analogue)8.129,2350.190.000
4des-Gly10-NH2 (−74 Da)8.073,4020.07-74.048
5oxidised Trp (+16 Da)8.011,9440.04+15.995
Closure check — purity + Σ impurities 100.00CLOSES

Reporting threshold 0.05 % area. Peaks below it are not reported and are therefore excluded from the total, which overstates purity by their sum — see peak integration.

Section 3

Mass spectrum and identity

Theoretical monoisotopic mass 1310.6248 Da, computed from C64H82N18O13. All ppm figures on this site are against monoisotopic values — see why that matters.

025507510032552572592511251325 [M+1H]1+1311.66[M+2H]2+656.33 m/z Relative abundance (%)
Figure 2. ESI charge-state envelope, unit-resolution instrument. Sticks are placed at m/z = (M + z × 1.007276)/z for the observed neutral mass of 1310.6485 Da. Sodium (+21.982/z) and potassium (+37.956/z) adducts are shown where the parent charge state exceeds 25 % relative abundance; they are adducts of the same molecule and are not impurities.
ChargeTheoretical m/zObserved m/zΔ m/zRel. abundance (%)
3+437.8822437.89010.00797.8
2+656.3197656.33150.011854.0
1+1311.63211311.65580.0237100.0
Section 4

Gravimetric mass balance

Water, counter-ion, residual and total peptide content are exhaustive and mutually exclusive categories. They must account for 100 % of the cake mass. The index closes this to within 0.02 pp and the build asserts it.

ComponentDetermination%w/w of cake
WaterKarl Fischer4.18
Counter-ion (acetate)ion chromatography4.09
Residual solvent + inorganic residueestimated0.47
Total peptide contentby difference91.26
Total100.00 CLOSES

Supplier certificate, as declared

The supplier's own figures for this lot, beside the independent measurement. Divergence is assessed against the batch median, not against this single report — see rule AX-R05.

FigureSupplier COAThis reportIndex note
Purity (% area)99.4299.46divergence -0.04 pp vs batch median
Total impurities (% area)0.580.54
Largest single impurity (% area)0.300.24
Water (%)3.74.18
Counter-ion (%)4.74.09
Peptide content (%w/w)91.091.26
Endotoxin (EU/mg)not statednot determined
Method stated on certificateNOno method section — the result cannot be reconciled against any other
Section 5

Provenance and caveats

Where a sample came from changes the weight of the evidence. The index treats it as a first-class field.

Sample provenance
Buyer-sourced
Evidentiary weight
Strongest available evidence in this index.
Chain of custody
Retail purchase → submitter (ambient, 7 d) → laboratory (courier, cold pack, 3 d) → assay.
Assay date
28 Feb 2026
Submitted to the index
09 Mar 2026
Laboratory
Medutest, Ljubljana, Slovenia
Method basis
25 min gradient · unit-resolution MS
Verification status
IDENTITY CONSISTENT
Section 6

Annotations 4

Signed technical comments from index contributors. Not a discussion forum — annotations question or contextualise the result, and the data team replies where a reply is warranted.

lot_traceability
Lot HYB-2512-B7307 decodes to a manufacture date consistent with the custody chain above. Traceability plus 99.46 % is a complete story; either alone is half of one.
retest_date
A retest date on the certificate would tell you what the supplier is actually asserting about stability. Purity at 99.46 % on assay day is a starting condition, not a shelf life.
esi_tof
No mass accuracy statement means much if the peak top is broad. Resolution and signal-to-noise at this mass are the real constraints and neither is on the certificate.
isotope_cluster
At this mass the monoisotopic peak may not be the most intense peak in the cluster. Picking the apex instead of the monoisotopic peak produces a systematic positive error of roughly the size flagged here.
Section 7

Related records

Same batch — lot HYB-2512-B7307 n=12

ReportLotLabQuarterPurity %Water %Recovery %ProvenanceFlagsResult
AX-2026-042060HYB-2512-B7307Janoshik2026-Q199.463.8694.9Buyer-sourced0PASS
AX-2026-042061HYB-2512-B7307Medutest2026-Q199.224.88100.4Laboratory-retained0PASS
AX-2026-042062HYB-2512-B7307PeptideMeter2026-Q199.934.16Buyer-sourced0PASS
AX-2026-042063HYB-2512-B7307PeptideMeter2026-Q199.934.2899.1Supplier-supplied0PASS
AX-2026-042065HYB-2512-B7307Medutest2026-Q199.404.83Buyer-sourced1MARGINAL
AX-2026-042066HYB-2512-B7307Medutest2026-Q199.484.68Buyer-sourced1FAIL
AX-2026-042067HYB-2512-B7307Medutest2026-Q199.604.31105.3Buyer-sourced0PASS
AX-2026-042068HYB-2512-B7307Janoshik2026-Q199.384.4088.8Buyer-sourced1MARGINAL
AX-2026-042069HYB-2512-B7307Janoshik2026-Q199.333.89Buyer-sourced0PASS
AX-2026-042070HYB-2512-B7307Janoshik2026-Q199.414.43Buyer-sourced0PASS
AX-2026-042071HYB-2512-B7307PeptideMeter2026-Q199.494.78106.6Buyer-sourced0PASS
Other recent Triptorelin records in the index.
ReportSupplierLotLabQuarterPurity %Water %Recovery %ProvenanceFlagsResult
AX-2026-041477QSCQSC-2607-C5749Nordanalyt2026-Q399.533.42Buyer-sourced0PASS
AX-2026-042060HYBHYB-2512-B7307Janoshik2026-Q199.463.8694.9Buyer-sourced0PASS
AX-2026-042068HYBHYB-2512-B7307Janoshik2026-Q199.384.4088.8Buyer-sourced1MARGINAL
AX-2026-042063HYBHYB-2512-B7307PeptideMeter2026-Q199.934.2899.1Supplier-supplied0PASS
AX-2026-042062HYBHYB-2512-B7307PeptideMeter2026-Q199.934.16Buyer-sourced0PASS
AX-2026-042061HYBHYB-2512-B7307Medutest2026-Q199.224.88100.4Laboratory-retained0PASS
AX-2026-042065HYBHYB-2512-B7307Medutest2026-Q199.404.83Buyer-sourced1MARGINAL
AX-2026-042069HYBHYB-2512-B7307Janoshik2026-Q199.333.89Buyer-sourced0PASS
Other recent HYB records in the index.
ReportCompoundLotLabQuarterPurity %Water %Recovery %ProvenanceFlagsResult
AX-2026-042083MOTS-cHYB-2606-D7858Medutest2026-Q399.932.02Buyer-sourced0PASS
AX-2026-042090MOTS-cHYB-2606-D7858Janoshik2026-Q399.572.36Buyer-sourced1FAIL
AX-2026-042084MOTS-cHYB-2606-D7858Janoshik2026-Q399.282.79107.3Buyer-sourced0PASS
AX-2026-042087MOTS-cHYB-2606-D7858Janoshik2026-Q399.543.05Buyer-sourced0PASS
AX-2026-042085MOTS-cHYB-2606-D7858Janoshik2026-Q399.512.31Buyer-sourced0PASS
AX-2026-042088MOTS-cHYB-2606-D7858PeptideMeter2026-Q399.222.21Buyer-sourced0PASS
AX-2026-042086MOTS-cHYB-2606-D7858Janoshik2026-Q399.933.02Buyer-sourced1MARGINAL
AX-2026-042091CJC-1295 with DACHYB-2608-E7391Janoshik2026-Q399.385.53Buyer-sourced0PASS